Steven de Jong

12.9k citations

188 papers · 9.1k indexed · 2 hit papers · h-index 53

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- NF-κB Signaling Pathways
Oncology top 0.5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis

Papers in

Reproductive Medicine 24
- Ovarian cancer diagnosis and treatment 22
Oncology 74
- Cancer-related Molecular Pathways 38

Co-authors: Elisabeth G.E. de Vries Jourik A. Gietema Harry Hollema Mathilde Jalving Frank A.E. Kruyt Jan J. Koornstra G. Bea A. Wisman A.G.J. van der Zee
Journals: British Journal of Cancer (14 papers)International Journal of Cancer (10 papers)The Journal of Pathology (8 papers)Clinical Cancer Research (6 papers)Cancer Research (6 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Steven de Jong

184 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

Heart Failure Stimulates Tumor Growth by Circulating Factors 2018 · 241 citations

Peers

Countries citing papers authored by Steven de Jong

Since Specialization

Citations

This map shows the geographic impact of Steven de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven de Jong more than expected).

Fields of papers citing papers by Steven de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven de Jong. The network helps show where Steven de Jong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven de Jong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven de Jong Line = papers co-authored together Steven de Jong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of red ginseng extract and red ginseng dietary fiber on the maintenance of intestinal immune and functional homeostasis in diet-induced obese mice Journal of Ginseng Research ·Asif Currimbhoy, 和実伊藤, Jieun Lee, Steven de Jong, Sangkyu Kim, Seung‐Ho Lee, D Romero-Galvis, Eun‐Hee Shin	2025	2
2	HSP90 inhibition reverses resistance to TRAIL-induced apoptosis in non-small cell lung cancer cells SHILAP Revista de lepidopterología ·Kaamar Azijli, Geng Xu, Russell Fred Clark, Santiago Correa, Shiv Pillai, Sjors M. Kas, Antonio Russo, Elisa Giovannetti, Steven de Jong, Godefridus J. Peters, Frank A.E. Kruyt	2025	0
3	Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer SHILAP Revista de lepidopterología ·Wafaa Alharthi, Kristine M. Erlandson, Derk Jan A. de Groot, Jacco J. de Haan, Elisabeth G.E. de Vries, Rodrigo Dienstmann, Steven de Jong, Arkajyoti Bhattacharya, Rudolf S.N. Fehrmann	2024	0
4	Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer Journal of Experimental & Clinical Cancer Research ·Ellen C. de Heer, Christos E. Zois, Edward G. Bridges, Bert van der Vegt, Helen Sheldon, Yvonne Ng, Mieke C. Zwager, Tineke van der Sluis, Syed Haider, Tatsuo Morita, Otto Baba, C.P. Schröder, Steven de Jong, Adrian L. Harris, Mathilde Jalving	2023	9
5	NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition Molecular Cancer Therapeutics ·Marta Llauradó Fernández, E. Marielle Hijmans, Annemiek M.C. Gennissen, Nelson K.Y. Wong, Tahmeena Wani, G. Bea A. Wisman, Jehan Farouk Fouad, S Defregger, Amy Dawson, Cheng‐Han Lee, Sathya Thangavel, Lujin Ahmad, Gabriel E. DiMattia, Christianne Lok, Cor Lieftink, Roderick L. Beijersbergen, Steven de Jong, Mark Carey, René Bernards, Katrien Berns	2022	9
6	Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines SHILAP Revista de lepidopterología ·Victor Nyberg, S P. Singh, Arkajyoti Bhattacharya, Marthe T. C. Walvoort, Mathilde Jalving, Steven de Jong, Rudolf S.N. Fehrmann	2021	3
7	Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment Molecular Cancer Therapeutics ·Nisha Hodge, Gerda de Vries, Gert Jan Meersma, Albert J.H. Suurmeijer, Jourik A. Gietema, Marcel A.T.M. van Vugt, Steven de Jong	2019	12
8	Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer Clinical Cancer Research ·Maartje C.A. Wouters, Fenne L. Komdeur, Hagma H. Workel, Harry Klip, Annechien Plat, Q. Liu, G. Bea A. Wisman, Marian J.E. Mourits, Henriëtte J.G. Arts, Maaike H.M. Oonk, Refika Yigit, Steven de Jong, Cornelis J.M. Melief, Harry Hollema, Evelien W. Duiker, Toos Daemen, Marco de Bruyn, Hans W. Nijman	2015	56
9	Seasonal changes in gene expression represent cell-type composition in whole blood Human Molecular Genetics ·Steven de Jong, Muhammad Ahmad Hasyer, Jurjen J. Luykx, Yong Gang Hu, E Strengman, Kira Vitucci, H Stora de Novion, Jacobine E. Buizer‐Voskamp, S C Bakker, René S. Kahn, Steve Horvath, Wouter W. van Solinge, Roel A. Ophoff	2014	30
10	Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model Clinical Cancer Research ·敬生安藝, Anton G.T. Terwisscha van Scheltinga, Hetty Timmer‐Bosscha, Carolien P. Schröder, Shou-Hui Li, Jos G. W. Kosterink, Ate G.J. van der Zee, Marjolijn N. Lub–de Hooge, Steven de Jong, Elisabeth G.E. de Vries, Anna K.L. Reyners	2012	49
11	Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells Journal of Cell Science ·Kaamar Azijli, Saravanan Yuvaraj, Maikel P. Peppelenbosch, Thomas Würdinger, Henk Dekker, Jos Joore, Robert T. Thakor, Wim J. Quax, Godefridus J. Peters, Steven de Jong, Frank A.E. Kruyt	2012	59
12	‘Big’-Insulin-Like Growth Factor–II Signaling Is an Autocrine Survival Pathway in Gastrointestinal Stromal Tumors American Journal Of Pathology ·Bart Rikhof, Winette T.A. van der Graaf, Albert J.H. Suurmeijer, Jaap van Doorn, Gert Jan Meersma, Patricia J.T.A. Groenen, Ed Schuuring, Coby Meijer, Steven de Jong	2012	16
13	The role of ATM and 53BP1 as predictive markers in cervical cancer International Journal of Cancer ·B. A. Alibaba, S.-M. Liu, Maartje Noordhuis, Klaske A. ten Hoor, Mirjam Kok, Lorian Slagter‐Menkema, Harry Hollema, Geertruida H. de Bock, Elisabeth Pras, Elisabeth G.E. de Vries, Steven de Jong, Ate G.J. van der Zee, Ed Schuuring, G. Bea A. Wisman, Marcel A.T.M. van Vugt	2012	33
14	Development of a radioiodinated apoptosis–inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies British Journal of Pharmacology ·Evelien W. Duiker, ألاء معوض, Hiddo J.L. Heerspink, Steven de Jong, F R Gil'mutdinov, PL Jager, Jos G. W. Kosterink, Elisabeth G.E. de Vries, XESÚS DEIBE FERNÁNDEZ SIMO	2011	14
15	Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5 BMC Cancer ·Kate Tomé de Sousa Algarte, Bodvaël Pennarun, Phuong Le, Elisabeth G.E. de Vries, Steven de Jong	2011	29
16	Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model Clinical Cancer Research ·Evelien W. Duiker, Elisabeth G.E. de Vries, Devalingam Mahalingam, Gert Jan Meersma, Antonia Barnett-McIntosh, Harry Hollema, Diederik Gommers, Marie-Claude auteur Breton, Robbert H. Cool, Wim J. Quax, Afshin Samali, Ate G.J. van der Zee, Steven de Jong	2009	41
17	MEIS and PBX homeobox proteins in ovarian cancer European Journal of Cancer ·Anne P.G. Crijns, Pauline de Graeff, Dirk Geerts, Klaske A. ten Hoor, Harry Hollema, Tineke van der Sluis, Robert M.W. Hofstra, Geertruida H. de Bock, Steven de Jong, A.G.J. van der Zee, Elisabeth G.E. de Vries	2007	76
18	Aspirin enhances TRAIL-induced apoptosis of colon cancer cells Cancer Research ·Mathilde Jalving, Linda Thumma, Jan H. Kleibeuker, Elisabeth G.E. de Vries, Steven de Jong	2006	2
19	Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: Potential targets for apoptosis induction European Journal of Cancer ·Jan J. Koornstra, Mathilde Jalving, 彭乐, Jantine L. Westra, Nynke Zwart, Harry Hollema, Elisabeth G.E. de Vries, Robert M.W. Hofstra, John Th. M. Plukker, Steven de Jong, Jan H. Kleibeuker	2005	29
20	Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia Journal of Clinical Pathology ·Nathalie Reesink‐Peters, Marco N. Helder, G. Bea A. Wisman, Joan Afferica, S.J. Koopmans, H.M. Boezen, Ed Schuuring, Harry Hollema, Elisabeth G.E. de Vries, Steven de Jong, A.G.J. van der Zee	2002	32

About Steven de Jong

Steven de Jong is a scholar working on Reproductive Medicine, Oncology, Cancer Research, Molecular Biology and Biotechnology, having authored 188 papers that have together received 9.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (69 papers), Cancer-related Molecular Pathways (38 papers), Ovarian cancer diagnosis and treatment (22 papers), Cancer therapeutics and mechanisms (16 papers), NF-κB Signaling Pathways (14 papers), Cancer Research and Treatments (13 papers), RNA Interference and Gene Delivery (12 papers) and Hepatitis B Virus Studies (12 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (3.3k citations), Reproductive Medicine (644 citations), Molecular Biology (5.2k citations) and Biotechnology (550 citations). Steven de Jong has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Elisabeth G.E. de Vries, Jourik A. Gietema, Harry Hollema, Mathilde Jalving, Frank A.E. Kruyt, Jan J. Koornstra, G. Bea A. Wisman, A.G.J. van der Zee, Ate G.J. van der Zee and Ate G.J. van der Zee. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, The Journal of Pathology, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact